Loading...
Planet 13 Holdings Inc.
PLTH.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.28
CA$0.005(1.82%)
Planet 13 Holdings Inc. (PLTH.CN) Financial Performance & Income Statement Overview
Review Planet 13 Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
18.18%
↑ 18.18%
Operating Income Growth
41.87%
↑ 41.87%
Net Income Growth
38.18%
↑ 38.18%
Operating Cash Flow Growth
142.48%
↑ 142.48%
Operating Margin
-31.64%
↓ 31.64%
Gross Margin
47.41%
↑ 47.41%
Net Profit Margin
-36.17%
↓ 36.17%
ROE
-33.05%
↓ 33.05%
ROIC
-21.55%
↓ 21.55%
Planet 13 Holdings Inc. (PLTH.CN) Income Statement & Financial Overview
Review Planet 13 Holdings Inc.'s (PLTH.CN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $30.28M | $32.16M | $31.08M | $22.78M |
| Cost of Revenue | $17.19M | $15.46M | $17.39M | $14.39M |
| Gross Profit | $13.09M | $16.70M | $13.69M | $8.39M |
| Gross Profit Ratio | $0.43 | $0.52 | $0.44 | $0.37 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $15.77M | $16.55M | $14.84M | $12.04M |
| Operating Expenses | $38.08M | $20.02M | $14.84M | $12.04M |
| Total Costs & Expenses | $55.27M | $35.48M | $32.23M | $26.42M |
| Interest Income | $0.00 | $30263.00 | $84580.00 | $24562.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $3.59M | $3.58M | $3.23M | $3.004M |
| EBITDA | -$2.52M | $255455.00 | $2.08M | -$647294.00 |
| EBITDA Ratio | -$0.08 | $0.008 | $0.07 | -$0.03 |
| Operating Income | -$24.98M | -$3.32M | -$1.15M | -$3.65M |
| Operating Income Ratio | -$0.82 | -$0.10 | -$0.04 | -$0.16 |
| Other Income/Expenses (Net) | -$149870.00 | $403914.00 | -$2.87M | $135214.00 |
| Income Before Tax | -$25.13M | -$2.92M | -$4.02M | -$3.51M |
| Income Before Tax Ratio | -$0.83 | -$0.09 | -$0.13 | -$0.15 |
| Income Tax Expense | $1.30M | $4.49M | $4.05M | $2.33M |
| Net Income | -$26.44M | -$7.41M | -$8.07M | -$5.85M |
| Net Income Ratio | -$0.87 | -$0.23 | -$0.26 | -$0.26 |
| EPS | -$0.09 | -$0.02 | -$0.03 | -$0.03 |
| Diluted EPS | -$0.09 | -$0.02 | -$0.03 | -$0.03 |
| Weighted Avg Shares Outstanding | $325.16M | $325.16M | $289.18M | $228.44M |
| Weighted Avg Shares Outstanding (Diluted) | $325.16M | $325.16M | $289.18M | $228.44M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan